@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C> a ns1:ATCConcept ;
    dcterms:title "Kardiovaskulární systém"@cs,
        "CARDIOVASCULAR SYSTEM"@en ;
    skos:notation "C" .

<http://linked.opendata.cz/resource/ATC/C09> a ns1:ATCConcept ;
    dcterms:title "Léčiva ovlivňující renin-angiotenzinový systém"@cs,
        "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"@en ;
    skos:notation "C09" .

<http://linked.opendata.cz/resource/ATC/C09B> a ns1:ATCConcept ;
    dcterms:title "ACE inhibitory, kombinace"@cs,
        "ACE INHIBITORS, COMBINATIONS"@en ;
    skos:notation "C09B" .

<http://linked.opendata.cz/resource/ATC/C09BA> a ns1:ATCConcept ;
    dcterms:title "ACE inhibitory a diuretika"@cs,
        "ACE inhibitors and diuretics"@en ;
    skos:notation "C09BA" .

<http://linked.opendata.cz/resource/ATC/C09BA08> a ns1:ATCConcept ;
    dcterms:title "Cilazapril a diuretika"@cs,
        "Cilazapril and diuretics"@en ;
    skos:broaderTransitive <http://linked.opendata.cz/resource/ATC/C>,
        <http://linked.opendata.cz/resource/ATC/C09>,
        <http://linked.opendata.cz/resource/ATC/C09B>,
        <http://linked.opendata.cz/resource/ATC/C09BA> ;
    skos:notation "C09BA08" .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0010703> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000431>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003529>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> ;
    ns1:description "A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.     "@en ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006624>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0471877> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B> ;
    ns1:title "Hydrochlorthiazid"@cs,
        "Hydrochlorothiazide"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026294> a ns1:Ingredient ;
    ns1:description "One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors) used for hypertension.  It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat.     "@en ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456> ;
    ns1:title "Cilazapril"@cs,
        "Cilazapril"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207> a ns1:PharmacologicalAction ;
    ns1:description "A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.     "@en ;
    ns1:title "Inhibitory angiotenzin konvertujícího enzymu"@cs,
        "Angiotensin-converting enzyme inhibitors"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     "@en ;
    ns1:title "Antihypertenzíva"@cs,
        "Antihypertensive agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006624> a ns1:PharmacologicalAction ;
    ns1:description "Agents that promote the excretion of urine through their effects on kidney function.     "@en ;
    ns1:title "Diuretika"@cs,
        "Diuretics"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0471877> a ns1:PharmacologicalAction ;
    ns1:description "Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.     "@en ;
    ns1:title "Symportéry pro chlorid sodný - inhibitory"@cs,
        "Sodium chloride symporter inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000431> a ns1:DiseaseOrFinding ;
    ns1:title "Anurie"@cs,
        "Anuria"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003529> a ns1:DiseaseOrFinding ;
    ns1:title "Selhání ledvin"@cs,
        "Kidney failure"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> a ns1:DiseaseOrFinding ;
    ns1:title "Těhotenství"@cs,
        "Pregnancy"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134865> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasMaximalPrice "416.359985352"^^xsd:float ;
    ns1:hasPackagingSize "28"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasReimbursementAmount "158.179992676"^^xsd:float ;
    ns1:hasResumedMarketingDate "2010-06-01"^^xsd:date ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 28"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134866> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "30"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 30"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134867> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "56"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 56"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134868> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "60"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 60"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134869> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "84"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 84"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134870> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "90"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 90"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134871> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasIndication """Přípravek Cazacombi 5 mg/12,5 mg je indikován k léčbě hypertenze u dospělých pacientů, u kterých není krevní tlak dostatečně upraven samotným cilazaprilem. 
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "98"^^xsd:string ;
    ns1:hasRegistrationState <http://linked.opendata.cz/resource/sukl/registration-state/R> ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument <http://linked.opendata.cz/resource/sukl/spc/document/SPC142417_doc> ;
    ns1:hasStrength "5MG/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 98"@cs ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/CAZACOMBI-5-MG-12-5-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C09BA08> ;
    ns1:hasActiveIngredient <http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0010703>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026294> ;
    ns1:hasMedicinalProductPackaging <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134865>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134866>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134867>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134868>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134869>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134870>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0134871> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B> ;
    ns1:title "CAZACOMBI 5 MG/12,5 MG"@cs .


